As a result, widespread PSA screening in men may lead to false positives and the overdiagnosis of non-aggressive conditions (4), and a PSA value between 4 and 10 is a gray area for distinguishing between prostate cancer and benign prostatic diseases. This evidence concerns the gene KLK3 and Familial prostate cancer.